Velnourish Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 47.55%
- Profit Growth 21.82%
- Ebitda -95.69%
- Net Worth 32.51%
- Total Assets 44.94%
About Velnourish Pharma
Velnourish Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 June 2017 (Seven years and seven months 21 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Corporate was formerly known as White Pepper Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.00 M.
Sonali Vijay, Khushboo Garg, and Abhinandan Sharma serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999RJ2017PTC058400
-
Company No.
058400
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jun 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Velnourish Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinandan Sharma
|
Director | 15-Apr-2021 | Current |
|
Sonali Vijay
|
Director | 24-Jun-2017 | Current |
|
Khushboo Garg
|
Director | 24-Jun-2017 | Current |
Financial Performance of Velnourish Pharma.
Velnourish Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.55% increase. The company also saw a substantial improvement in profitability, with a 21.82% increase in profit. The company's net worth Soared by an impressive increase of 32.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velnourish Pharma?
Unlock access to Velnourish Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2022 | Hdfc Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Velnourish Pharma?
Unlock and access historical data on people associated with Velnourish Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velnourish Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velnourish Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
